Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure- activity relationship

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 729-734

  Fowler, Christopher J ^a   Tiger, Gunnar ^a   Stenström, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANANDAMIDE; BENZYLSULFONYL FLUORIDE; DICLOFENAC; FENOPROFEN; HYDROCINNAMIC ACID; IBUPROFEN; ISOBUTYRIC ACID; KETOPROFEN; NAPROXEN; PARACETAMOL; SULINDAC; SUPROFEN;

ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN REGION; CANNABIS ADDICTION; CONTROLLED STUDY; DEAMINATION; DRUG MECHANISM; DRUG METABOLISM; INFLAMMATION; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACIDS; BRAIN; IBUPROFEN; POLYUNSATURATED ALKAMIDES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030730417     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. CHILDERS, S. R., SEXTON, T. AND ROY, M. B.: Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol. 47: 711-715, 1994.
2. COOPER, S. A., WAGENBERG, B., Zissu, J., KRUGER, G. O., REYNOLDS, D. C., GALLEGOS, L. T., ALLWEIN, J. B., DESJARDINS, P. J., FRIEDMANN, N. AND DANNA, R. P.: The analgesic efficacy of suprofen in periodontal and oral surgical pain. Pharmacotherapy 6: 267-276, 1986.
3. CORNISH-BOWDEN, A.: Principles of Enzyme Kinetics. Butterworth, London, 1976.
4. D'AMBRA, T. E., ESTEP, K. G., BELL, M. R., EISSENSTAT, M. A., JOSEF, K. A., WARD, S. J., HAYCOCK, D. A., BAIZMAN, E. R., CASIANO, F. M., BEGLIN, N. C., CHIPPARI, S. M., GREGO, J. D., KULLNIG, R. K. AND DALEY, G. T.: Conformationally restrained analogues of pravadoline: Nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. J. Med. Chem. 35: 124-135, 1992.
5. DERKINDEREN, P., TOUTANT, M., BURGAYA, F., LE BERT, M., SICILIANO, J. C., DE FRANCISCIS, V., GELMAN, M. AND GIRAULT, J.-A.: Regulation of a neuronal form of focal adhesion kinase by anandamide. Science (Wash. DC) 273: 1719-1722, 1996.
6. DESARNAUD, F., CADAS, H. AND PIOMELLI, D.: Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J. Biol. Chem. 270: 6030-6035, 1995.
7. DEUTSCH, D. G. AND CHIN, S. A.: Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 46: 791-796, 1993.
8. DEVANE, W. A., HANUS, L., BREUER, A., PERTWEE, R. G., STEVENSON, L. A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. AND MECHOULAM, R.: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash. DC) 258: 1946-1949, 1992.
9. DEWEY, W. L.: Cannabinoid pharmacology. Pharmacol. Rev. 38: 151-178, 1986.
10. EISENTHAL, R. AND CORNISH-BOWDEN, A.: The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters. Biochem. J. 139: 715-720, 1974.
11. FORBES, J. A., BEAVER, W. T., JONES, K. F., EDQUIST, I. A., GONGLOFF, C. M., SMITH, W. K., SMITH, F. G. AND SCHWARTZ, M. K.: Analgesic efficacy of bromfenac, ibuprofen, and aspirin in postoperative oral surgery pain. Clin. Pharmacol. Ther. 51: 343-352, 1992.
12. FOWLER, C. J., STENSTRÖM, A. AND TIGER, G.: Ibuprofen inhibits the metabolism of the endogenous cannabimimetic agent anandamide. Pharmacol. Toxicol. 80: 103-107, 1997.
13. HILIARD, C. J., WILKISON, D. M., EDGEMOND, W. S. AND CAMPBELL, W. B.: Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim. Biophys. Acta 1257: 249-256, 1995.
14. INSEL, P. A.: Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th Ed., ed. by J. G. Hardman, A. Goodman Gilman and L. E. Limbard, pp. 617-657, McGraw-Hill, New York, 1996.
15. KARTTUNEN, P., SAANO, V., PARONEN, P., PEURA, P. AND VIDGREN, M.: Pharmacokinetics of ibuprofen in man: A single-dose comparison of two over-the-counter, 200 mg preparations. Int. J. Clin. Pharmacol. Ther. Toxicol. 28: 251-255, 1990.
16. KOUTEK, B., PRESTWICH. G. D., HOWLETT, A. C., CHIN, S. A., SALEHANI, D., AKHAVAN, N. AND DEUTSCH, D. G.: Inhibitors of arachidonoyl ethanolamide hydrolysis. J. Biol. Chem. 269: 22937-22940, 1994.
17. LANG, W., QIN, C., HILL, W. A. G., LIN, S., KHANOLKAR, A. D. AND MAKRIYANNIS, A.: High-performance liquid chromatographic determination of anandamide amidase activity in rat brain microsomes. Analyt. Biochem. 238: 40-45, 1996.
18. MACKIE, K., DEVANE, W. A. AND HILLE, B.: Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44: 498-503, 1993.
19. MAURELLI, S., BISOGNO, T., DE PETROCELLIS, L., LUCCIA, A. D., MARINO, G. AND DI MARZO, V.: Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma "anandamide amidohydrolase." FEBS Letts. 377: 82-86, 1995.
20. MITCHELL, J. A., AKARASEREENONT, P., THIEMERMANN, C., FLOWER, R. J. AND VANE, J. R.: Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. U.S.A. 90: 11693-11697, 1994.
21. 14C] as a substrate for anandamide amidase. Life Sci. 56: 1999-2005, 1995.
22. RICHARDSON, J. D., AANONSEN, L. AND HARGREAVES, K. M.: SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice Eur. J. Pharmacol. 319: R3-R4, 1997.
23. SHEN, M., PISER, T. M., SEYBOLD, V. S. AND THAYER, S. A.: Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16: 4322-4334, 1996.
24. SMITH, P. B., COMPTON, D. R., WELCH, S. P., RAZDAN, R. K., MECHOULAM, R. AND MARTIN, B. R.: The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270: 219-227, 1994.
25. TERRANOVA, J. P., MICHAUD, J. C., LE FUR, G. AND SOUBRIE, P.: Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: Reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 352: 576-579, 1995.
26. UEDA, N., KURAHASHI, Y., YAMAMOTO, S. AND TOKUNAGA, T.: Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem. 270: 23823-23827, 1995.
27. VOGEL, Z., BARG, J., LEVY, R., SAYA, D., HELDMAN, E. AND MECHOULAM, R.: Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem. 61: 352-355, 1993.